news
Antibody targets create potential for a unified treatment approach
Antibody targets thought to cause the most damage in neurological disorders, creates potential for a unified treatment approach...
List view / Grid view
Antibody Discovery
news
Proteomics accurately detect exposure to Zika virus
Researchers have used proteomics to examine proteins and peptides in saliva to accurately detect exposure to Zika virus...
news
Novel immuno-oncology treatment for patients with advanced solid tumours
An experimental immuno-oncology treatment will move into early phase clinical trials for patients with advanced solid tumours...
news
Numab and Kaken enter into an antibody collaboration
Numab Therapeutics announced a collaboration and option agreement with Kaken Pharmaceutical for the identification of a multispecific antibody candidate for development in inflammatory disease.
news
Abeome and CDC to collaborate on Zika antibody discovery
The Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito, is an impending threat to America’s borders, with over 5000 cases now reported in the continental US. Zika virus infection has been associated with Guillain-Barré Syndrome, and infection during pregnancy has been…
article
Antibodies In-Depth Focus 2017
Lone Friis and David Matthews discuss developability assessment of therapeutic antibodies, and Negin Mokhtari and colleagues explain nanoparticle-mediated enzyme delivery for application in cancer therapy...
news
Tri-I TDI expands focus to include antibody drug discovery
17 June 2016 | By Victoria White, Digital Content Producer
Tri-I TDI will extend its current relationship with Takeda from the realm of small molecule discovery into the new research area of antibody drug discovery...
whitepaper
Whitepaper: Further considerations of antibody validation and usage – how to avoid reviewer challenges
The effective use of antibodies in research assays has always depended on multiple factors that determine the accuracy and precision of the component reagents...
news
Heptares and Kymab enter antibody collaboration
18 April 2016 | By Victoria White, Digital Content Producer
Heptares and Kymab are to colllaborate to discover, develop and commercialise novel antibody therapeutics targeting a number of GPCRs...
news
MRC Technology and IPS-CAS in antibody drug discovery collaboration
6 April 2016 | By Victoria White
The parties created IPS-MRCT Joint Centre for Therapeutic Antibodies in order to combine their expertise in research and development...
news
Cellectis and MabQuest to develop new class of anti-PD-1 mAbs
17 March 2016 | By Victoria White
These anti-PD-1 mAbs have potential uses for multiple indications in immunotherapy, including notably treatments for a variety of cancers...
news
Single antibody protects non-human primates from Ebola virus
26 February 2016 | By Victoria White
A single monoclonal antibody isolated from a human survivor of Ebola virus completely protected monkeys from lethal infection with the virus...
news
Teva and AbCellera team up to discover monoclonal antibodies
3 February 2016 | By Victoria White
AbCellera will apply its high-throughput single cell antibody platform for the discovery of the rare monoclonal antibodies...
news
AbCellera and MSD enter antibody collaboration
28 January 2016 | By Victoria White
Under the agreement, AbCellera will apply its high-throughput antibody discovery platform to identify antibodies that specifically modulate target function...
news
Researchers isolate antibodies that neutralise multiple species of Ebola
22 January 2016 | By Victoria White
Researchers used a high-efficiency method they developed to quickly isolate and generate large quantities of monoclonal human antibodies from the blood of survivors of a 2007 outbreak in Uganda who were infected by the Bundibugyo Ebola virus...